Clinical Trials Logo

Clinical Trial Summary

This study aims is the evaluation of the efficacy and feasibility of RinasciMENTE, the Randomized Controlled Clinical Trial compared with a waiting list control group.


Clinical Trial Description

A sample of 128 participants, who experience psychological discomfort due to COVID-19, will be recruited. After initial screening, participants will be randomly assigned to either an experimental group or a waiting list group. Measures will be taken at the baseline (T0), at the end of the treatment (T1) and 12 months follow-up (T2). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04907903
Study type Interventional
Source Catholic University of the Sacred Heart
Contact Vanessa Bertuzzi
Phone 347-4752286
Email vanessa.bertuzzi@unicatt.it
Status Not yet recruiting
Phase N/A
Start date September 1, 2022
Completion date June 1, 2023

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05153109 - Reliabilty and Validity of a Diagnostic Interview for Parents of Babies and Preescholers
Completed NCT04475055 - Reliability and Validity of the DIPS (Structured Interview) in a Community Sample
Completed NCT04450238 - The Dual Factor Model of Mental Health in Inpatients
Completed NCT04453475 - Feasibility and Benefits of Digital Services During the COVID19 Pandemic N/A
Recruiting NCT06011642 - Reliability and Validity of a Digital Version of a Structured Interview for Children and Adolescents (Kinder-eDIPS)
Completed NCT05238415 - ASAP - Assisted Immediate Augmented Post-/Long-COVID Plan for Patients Infected With COVID-19 N/A